Gara Jalqabaatti › Kansarii Pancreas › Maryland › Baltimore
Qorannoo klinikaalii Kansarii Pancreas Baltimore, MD keessatti
Qorannoo 31 Kansarii Pancreas f Baltimore fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 2
- Johns Hopkins University, Baltimore
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
Namoota walitti qabaa jiraSadarkaa 3
- Johns Hopkins University, Baltimore
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Namoota walitti qabaa jiraSadarkaa 2/3
- JHU Oncology Central Kit Services, Baltimore
- Johns Hopkins Hospital, Baltimore
- Oncology Investigational Drug Service (IDS), Baltimore
- fi 1 dabalataa
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Namoota walitti qabaa jiraSadarkaa 3
- Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins & Sibley Memorial Hospital, Baltimore
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
Namoota walitti qabaa jiraSadarkaa 3
- University of Maryland School - Division of Hematology/Oncology, Baltimore
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- The Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore
Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
Namoota walitti qabaa jiraQorannoo ilaalaa
- The Johns Hopkins University School of Medicine, Baltimore
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Johns Hopkins, Baltimore
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Namoota walitti qabaa jiraSadarkaa 2
- Johns Hopkins Hospital, Baltimore
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
Namoota walitti qabaa jiraQorannoo ilaalaa
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Total Pancreatectomy With Islet Autotransplantation (TPIAT) for High-Risk Patients With Pancreatic Tumors
Namoota walitti qabaa jira
- Johns Hopkins Hospital, Baltimore
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Johns Hopkins University, Baltimore
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Sinai Hospital of Baltimore, Baltimore
Pancreatic Cancer Registry: For Any Person With a Personal or Family History
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Johns Hopkins Hospital, Baltimore
KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer
Namoota walitti qabaa jiraSadarkaa 1
- Sidney Kimmel Comprehensive Cancer Center, Baltimore
EXoPERT EMERALD Clinical Study
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- John Hopkins University, Baltimore
Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
- Sidney Kimmel Comprehensive Cancer Center, Baltimore
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Johns Hopkins University, Baltimore
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
- Johns Hopkins Hospital, Baltimore
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
Namoota walitti qabaa jiraSadarkaa 3
- Sinai Hospital of Baltimore, Baltimore
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Namoota walitti qabaa jiraSadarkaa 1/2
- Johns Hopkins University, Baltimore
NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Sidney Kimmel Comprehensive Cancer Center, Baltimore
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Johns Hopkins University, Baltimore
Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts
Namoota walitti qabaa jiraQorannoo ilaalaa
- The Johns Hopkins Hospital, Baltimore
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Namoota walitti qabaa jiraSadarkaa 2
- Ohio State University-Telemedicine, Baltimore
Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer
Namoota walitti qabaa jiraSadarkaa 1/2
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Towson · Miili 8 fagaatti
The Cancer of the Pancreas Screening-5 CAPS5)Study
Namoota walitti qabaa jiraSadarkaa 3
- Johns Hopkins Hospital, Baltimore
Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions
Namoota walitti qabaa jiraQorannoo ilaalaa
- The Johns Hopkins Hospital, Baltimore
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
- Johns Hopkins, Baltimore
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Johns Hopkins Hospital, Baltimore
Qorannoo Kansarii Pancreas magaalota biroo keessatti
- Houston, TXQorannoo 61
- New York City, NYQorannoo 60
- Boston, MAQorannoo 43
- Nashville, TNQorannoo 39
- Los Angeles, CAQorannoo 35
- St. Louis, MOQorannoo 33
- Arlington, VAQorannoo 33
- San Antonio, TXQorannoo 31
- Philadelphia, PAQorannoo 26
- Tampa, FLQorannoo 26
- Durham, NCQorannoo 24
- San Diego, CAQorannoo 24
Qorannoo biroo Baltimore keessatti
- Kansara Qara'a Non-Small CellQorannoo 60
- Saree OljooQorannoo 47
- Kansarii ProstateQorannoo 43
- Dhibee QaraQorannoo 40
- Saree (Gosoota Hunda)Qorannoo 37
- Kansarii ColorectalQorannoo 31
- Kansara MetastatikiiQorannoo 28
- ObesityQorannoo 26
- Dukkana BladderQorannoo 24
- Cufama OnneeQorannoo 24
- Kansarii OvariiQorannoo 22
- StrokeQorannoo 21
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.